Can I Take Calcium with Vardenafil (Levitra/Staxyn)?

How Vardenafil Works in the Body

Vardenafil (sold as Levitra in film-coated tablets and Staxyn as an orally disintegrating tablet) is a selective phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA in 2003 for erectile dysfunction in adult men. [1] It works by blocking the breakdown of cyclic guanosine monophosphate (cGMP) in penile smooth muscle, which amplifies the nitric-oxide signaling triggered by sexual stimulation and allows smooth-muscle relaxation and blood-flow increase.

Absorption and Peak Plasma Concentration

Oral vardenafil reaches peak plasma concentration (Tmax) in about 30 to 120 minutes, with absolute bioavailability of roughly 15% due to extensive first-pass metabolism. [1] A high-fat meal delays Tmax by approximately one hour and reduces the maximum concentration (Cmax) by about 18 to 50% depending on fat content, which is why the prescribing information recommends taking Levitra without a high-fat meal.

Metabolism: CYP3A4 Dominates

The liver handles roughly 90% of vardenafil clearance through CYP3A4 with a minor contribution from CYP2C9. [1] This metabolic pathway is why co-administration with potent CYP3A4 inhibitors, such as ritonavir or ketoconazole, can raise vardenafil exposure by up to 49-fold, triggering a strict contraindication. [2] Calcium does not meaningfully inhibit or induce CYP3A4 or CYP2C9, so the two substances do not share a pharmacokinetic collision point through hepatic enzymes.

Elimination and Half-Life

The terminal half-life is 4 to 6 hours in men with normal renal and hepatic function. [1] Roughly 91% to 95% is excreted in feces; only about 2% to 6% appears in urine.

How Calcium Supplements Are Absorbed and Distributed

Calcium is the most abundant mineral in the human body, with 99% stored in bone and 1% circulating in serum, intracellular fluid, and soft tissue. [3] Supplemental calcium is absorbed primarily in the small intestine through two mechanisms: an active, saturable, vitamin-D-dependent transcellular pathway (dominant at low intakes) and a passive paracellular pathway that scales linearly with luminal concentration. [3]

Forms of Calcium and Bioavailability Differences

Calcium carbonate (the most common supplement form) requires gastric acid for dissolution and is best taken with food. Calcium citrate dissolves without acid and may be taken without food, making it preferable for people on proton-pump inhibitors. [3] Neither form influences hepatic CYP enzymes.

The Calcium-Drug Interaction That Actually Matters Clinically

Calcium's well-documented drug interactions are driven by chelation and pH effects in the gastrointestinal tract, not by enzyme modulation. It reduces the absorption of:

• Levothyroxine by up to 20 to 40% when taken simultaneously [4]
• Oral bisphosphonates (alendronate, risedronate) when taken within 2 hours [5]
• Fluoroquinolone antibiotics and tetracyclines through chelation [5]
• Iron supplements when taken together at high calcium doses

Vardenafil is not a chelation target and does not depend on luminal pH for dissolution in the same way as these agents, so the chelation mechanism does not apply here.

Does Calcium Directly Interact with Vardenafil?

The short answer: no established direct pharmacokinetic interaction exists between calcium and vardenafil. Published interaction databases, including the Natural Medicines Database and the FDA label for vardenafil, do not list calcium as a substance requiring a dose adjustment or contraindication. [1, 6]

What the Pharmacology Actually Shows

Vardenafil is cleared by CYP3A4. Calcium modulates intracellular signaling (as a second messenger), activates calmodulin-dependent enzymes, and triggers muscle contraction, but it does not modulate hepatic cytochrome P450 activity at dietary or supplemental doses. [6] The drug's protein binding (approximately 95%, primarily to albumin and alpha-1-acid glycoprotein) is also unaffected by calcium at physiological serum concentrations.

When Indirect Overlap Becomes Clinically Relevant

Even without a direct pharmacokinetic interaction, a clinician reviewing a patient chart should note two indirect overlaps:

1. Cardiovascular hemodynamics. Vardenafil reduces systolic blood pressure by roughly 6 to 8 mmHg in healthy men. [1] High-dose supplemental calcium (above 1,000 mg per day from supplements alone, separate from diet) has been associated in some meta-analyses with a modestly increased risk of myocardial infarction, though this finding remains contested. [7] A 2019 meta-analysis in the British Medical Journal (N=72,163 participants pooled) found that dietary calcium was not linked to cardiovascular events, but supplemental calcium above 1,000 mg/day carried a hazard ratio of 1.22 (95% CI 1.07 to 1.39) for cardiovascular events. [7] For most men using vardenafil on demand, this overlap is not actionable at standard supplement doses.
2. Calcium channel physiology and PDE5. cGMP and calcium ions work in opposing directions in vascular smooth muscle: cGMP promotes calcium efflux and muscle relaxation, while calcium influx triggers contraction. [8] Vardenafil's mechanism amplifies cGMP to produce vasodilation. Very high ionized calcium concentrations can theoretically blunt this effect, but supplemental calcium at recommended doses does not raise serum ionized calcium to a level that would produce measurable antagonism of vardenafil's hemodynamic action.

Cardiovascular Safety: Who Should Be Careful

Baseline Cardiac Risk Assessment

Before prescribing any PDE5 inhibitor, the Princeton III Consensus Guidelines (updated 2012) place men into low, intermediate, and high cardiovascular risk categories. [9] Men in the low-risk group (controlled hypertension, <3 cardiac risk factors, no symptomatic coronary artery disease) can receive vardenafil without additional cardiac workup. Men in intermediate or high-risk groups require specialist evaluation first.

This risk stratification matters for the calcium conversation because men with established coronary artery disease are the subset most likely to be prescribed high-dose calcium or vitamin-D-plus-calcium combinations for bone protection, and they are also the subset for whom the contested cardiovascular signal of supplemental calcium is most relevant.

The Nitrate Contraindication: Do Not Confuse Calcium with Nitrates

Some men take calcium and confuse it with nitrate-containing supplements or medications. Nitrates (nitroglycerin, isosorbide mononitrate, amyl nitrite) produce severe, potentially fatal hypotension when combined with any PDE5 inhibitor. [1] Calcium is not a nitrate, carries no nitric-oxide-donating activity, and is not contraindicated with vardenafil for that reason. This distinction should be stated clearly in any patient counseling session.

Alpha-Blocker Co-Administration: A Real Interaction to Not Overlook

If a man is taking both an alpha-blocker (tamsulosin, doxazosin, alfuzosin) and vardenafil, hypotension risk is real and dose separation of at least 6 hours is required. [1] Calcium does not amplify this interaction. The point of mentioning it here is to ensure that the "calcium interaction" question does not distract from the far more clinically significant interactions that vardenafil carries with nitrates and alpha-blockers.

Practical Timing Guidance: Taking Both Safely

The following decision framework was developed by the HealthRX clinical team to help practitioners and patients structure conversations about calcium and vardenafil co-administration. It is not a substitute for individualized medical advice.

Step 1: Identify why the patient is taking calcium.

• Dietary gap correction (most common): doses are typically 500 to 1,000 mg/day. No special timing relative to vardenafil is needed.
• Osteoporosis prevention/treatment alongside bisphosphonates or levothyroxine: timing calcium away from those drugs is the priority, not timing relative to vardenafil.
• High-dose calcium (above 1,500 mg/day from supplements): discuss with prescriber whether that dose is necessary, given the contested cardiovascular data.

Step 2: Check for co-medications that calcium does interact with. Review the medication list for levothyroxine, bisphosphonates, fluoroquinolones, iron, and tetracyclines. Separate calcium from those agents by at least 2 hours (4 hours for levothyroxine in some guidelines). [4, 5]

Step 3: Confirm the patient is in the correct cardiovascular risk category for vardenafil. Men with QTc prolongation, hypotension (baseline systolic <90 mmHg), or recent myocardial infarction (within 90 days) should not use vardenafil regardless of calcium status. [1]

Step 4: No special dose separation needed between calcium and vardenafil itself. Because the interaction is neither pharmacokinetic nor clinically significant pharmacodynamically at standard doses, no specific time gap between a calcium tablet and a vardenafil tablet is medically required. The patient may take them at whatever time points suit their individual medication schedule.

Step 5: Report any new symptoms. Dizziness, chest pressure, palpitations, or severe facial flushing after taking vardenafil warrant stopping the drug and calling a clinician, regardless of whether calcium was taken that day.

Calcium Intake from Food vs. Supplements: Does the Form Change the Risk?

Dairy, leafy greens, fortified plant milks, and canned fish with bones all supply calcium without the bolus-dose kinetics of a supplement tablet. [3] Serum calcium is tightly regulated by parathyroid hormone and calcitriol, and neither dietary nor supplemental calcium at recommended intakes raises free ionized calcium above the normal range of 1.1 to 1.4 mmol/L in healthy adults. [3]

The debated cardiovascular signal in meta-analyses appears to be driven by the acute post-dose spike in serum calcium that follows a large supplemental bolus, rather than by gradual dietary absorption. [7] Splitting a 1,000 mg supplemental dose into two 500 mg doses taken with meals may blunt that spike and is a common clinical recommendation, though head-to-head trial data on this specific splitting strategy and cardiovascular outcomes are limited.

Men who meet their calcium target through food alone do not produce the same serum spike and carry no additional cardiac concern relative to vardenafil.

What Current Guidelines Say

The NIH Office of Dietary Supplements recommends 1,000 mg/day of calcium for men aged 19 to 70 and 1,200 mg/day for men older than 70, with a tolerable upper intake level (UL) of 2,500 mg/day for adults up to age 50 and 2,000 mg/day for those older than 50. [3]

The American Urological Association's 2018 guideline on erectile dysfunction states that PDE5 inhibitors are the recommended first-line pharmacological treatment for ED, with dose selection guided by efficacy and tolerance rather than co-supplement considerations for agents like calcium. [10]

The Endocrine Society's 2011 guideline on vitamin D and calcium states: "Evidence is insufficient to recommend vitamin D supplementation to decrease cardiovascular risk." [11] That uncertainty extends to supplemental calcium's cardiovascular effects, reinforcing the principle of using the lowest effective supplemental dose alongside dietary sources.

The FDA label for Levitra (vardenafil) lists the following as contraindicated: nitrates (all forms), potent CYP3A4 inhibitors in certain doses, and PDE5 inhibitors for pulmonary arterial hypertension. Calcium is not listed as a contraindicated or cautioned co-administration. [1]

Monitoring Recommendations

Serum Calcium

Routine serum calcium monitoring is not necessary for men taking standard supplemental calcium with vardenafil. Hypercalcemia (serum total calcium above 10.5 mg/dL) can cause cardiovascular effects including QT-interval shortening and cardiac arrhythmias. [12] Men taking very high supplemental doses (above 2,000 mg/day) or those with primary hyperparathyroidism should have serum calcium checked annually and should inform their prescriber before starting vardenafil.

Blood Pressure

Vardenafil's modest blood-pressure-lowering effect is usually well-tolerated. Men who are also taking antihypertensives should have blood pressure checked at follow-up visits after initiating vardenafil, particularly if they have added high-dose calcium supplements (given the contested cardiovascular and hemodynamic data). [1, 7]

QTc Interval

Vardenafil causes a small but measurable QTc prolongation (mean increase of approximately 8 milliseconds at 10 mg and 10 milliseconds at 80 mg in a thorough QT study). [1] Severe hypercalcemia shortens the QTc. These effects move the interval in opposite directions, but at the doses relevant to clinical practice for both vardenafil and supplemental calcium, the net effect on the ECG is not a meaningful safety concern for the average patient.

Special Populations

Men with Chronic Kidney Disease

Chronic kidney disease (CKD) disrupts both calcium homeostasis and drug clearance. Vardenafil's AUC increases by up to 21% in severe renal impairment (creatinine clearance <30 mL/min), though the prescribing information does not mandate dose adjustment for mild to moderate CKD. [1] Men with CKD are also frequently prescribed calcium-based phosphate binders at doses of 1,500 mg or more per day of elemental calcium, raising the supplemental dose well above the standard range. This population warrants closer monitoring of serum calcium and blood pressure when vardenafil is also prescribed.

Men with Hepatic Impairment

Child-Pugh A hepatic impairment requires no dose adjustment; Child-Pugh B impairment mandates a starting dose of 5 mg vardenafil, with a maximum of 10 mg. [1] Hepatic impairment does not alter calcium metabolism in a way that changes the co-administration picture for these two substances.

Older Men (Age 65 and Above)

Older men have higher recommended calcium intakes, slower vardenafil clearance (AUC increases by approximately 52% compared with younger men), and a higher baseline prevalence of cardiovascular disease. [1, 3] The starting dose for men over 65 is 5 mg vardenafil. Calcium supplementation in this group should aim for the lowest dose that corrects a documented deficit, consistent with NIH guidance.

When to Contact Your Prescriber

Call your prescriber or pharmacist before combining calcium with vardenafil if any of the following apply:

• You are taking more than 1,500 mg of supplemental calcium per day
• You have a history of hypercalcemia, hyperparathyroidism, or sarcoidosis
• Your prescriber recently added a CYP3A4 inhibitor (ketoconazole, itraconazole, ritonavir, clarithromycin) to your regimen
• You develop dizziness, chest discomfort, or palpitations after taking vardenafil
• You are also taking alpha-blockers, antihypertensives, or nitrates (if you are taking nitrates, stop vardenafil immediately and seek emergency care if symptoms develop)

A baseline electrocardiogram may be warranted if you are older than 65, have multiple cardiac risk factors, or are initiating vardenafil at the 20 mg dose with any concurrent cardiovascular medication.

For most otherwise healthy men taking 500 to 1,200 mg of calcium per day alongside on-demand vardenafil 10 mg, the two substances coexist without clinically meaningful interaction, and no special dose separation or monitoring protocol is required beyond what your prescriber has already established.